FORM OF SHARE SUBSCRIPTION AGREEMENTShare Subscription Agreement • February 28th, 2017 • BeyondSpring Inc. • Pharmaceutical preparations • New York
This SHARE SUBSCRIPTION AGREEMENT (this “Agreement”) is entered into as of [●], 2017, by and between BeyondSpring Inc., a Cayman Islands company (the “Company”), and the undersigned (the “Investor”).
Underwriting Agreement BeyondSpring Inc. [●] Ordinary Shares plus an option to purchase from the Company up to [●] Ordinary Shares to cover over-allotmentsUnderwriting Agreement • February 28th, 2017 • BeyondSpring Inc. • Pharmaceutical preparations • New York
BeyondSpring Inc., a Cayman Islands company (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representative”) are acting as representative, [●] ordinary shares, par value $0.0001 per share (“Ordinary Shares”), of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Shares”). The Company also proposes to grant to the Underwriters an option to purchase up to [●] additional Ordinary Shares to cover over-allotments, if any (the “Option Shares” and, together with the Underwritten Shares, the “Shares”).
SHARE SUBSCRIPTION AGREEMENTShare Subscription Agreement • February 28th, 2017 • BeyondSpring Inc. • Pharmaceutical preparations • New York
This SHARE SUBSCRIPTION AGREEMENT (this “Agreement”) is entered into as of February 27, 2017, by and between BeyondSpring Inc., a Cayman Islands company (the “Company”), and Sangel Star Biomedical Fund LP, a Delaware limited partnership (the “Investor”).
